EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 26 filers reported holding EVOGENE LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,940 | -48.5% | 8,425 | -5.6% | 0.00% | – |
| Q2 2023 | $9,585 | +70.8% | 8,925 | 0.0% | 0.00% | – |
| Q1 2023 | $5,613 | -6.4% | 8,925 | 0.0% | 0.00% | – |
| Q4 2022 | $6,000 | -14.3% | 8,925 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 8,925 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 8,925 | +20.2% | 0.00% | – |
| Q1 2022 | $10,000 | -16.7% | 7,425 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -40.0% | 7,425 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -13.0% | 7,425 | +7.6% | 0.00% | – |
| Q2 2021 | $23,000 | -34.3% | 6,900 | 0.0% | 0.00% | – |
| Q1 2021 | $35,000 | +1650.0% | 6,900 | +1633.7% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 398 | +12.4% | 0.00% | – |
| Q3 2020 | $1,000 | – | 354 | +27.3% | 0.00% | – |
| Q2 2020 | $0 | – | 278 | +1058.3% | 0.00% | – |
| Q1 2020 | $0 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,100,000 | $1,818,150 | 0.55% |
| CVI Holdings, LLC | 261,636 | $153,214 | 0.30% |
| Malaga Cove Capital, LLC | 12,000 | $7,038 | 0.00% |
| Csenge Advisory Group | 30,762 | $18,042 | 0.00% |
| Joel Isaacson & Co., LLC | 30,300 | $17,771 | 0.00% |
| Walleye Capital LLC | 517,092 | $302,809 | 0.00% |
| Virtu Financial LLC | 11,605 | $7 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $5,865 | 0.00% |
| Sigma Planning Corp | 50,985 | $29,903 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,692 | $8,617 | 0.00% |